1. Home
  2. BWMN vs PRTA Comparison

BWMN vs PRTA Comparison

Compare BWMN & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowman Consulting Group Ltd.

BWMN

Bowman Consulting Group Ltd.

N/A

Current Price

$42.79

Market Cap

508.6M

ML Signal

N/A

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

N/A

Current Price

$9.15

Market Cap

429.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BWMN
PRTA
Founded
1995
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
508.6M
429.2M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
BWMN
PRTA
Price
$42.79
$9.15
Analyst Decision
Hold
Hold
Analyst Count
5
6
Target Price
★ $43.00
$21.40
AVG Volume (30 Days)
345.3K
★ 438.0K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 329.41
N/A
EPS
N/A
★ 0.26
Revenue
★ $490,017,000.00
$814,000.00
Revenue This Year
$21.26
$758.69
Revenue Next Year
$18.02
N/A
P/E Ratio
★ N/A
$33.12
Revenue Growth
★ 14.88
N/A
52 Week Low
$25.07
$7.73
52 Week High
$45.83
$11.80

Technical Indicators

Market Signals
Indicator
BWMN
PRTA
Relative Strength Index (RSI) 80.78 57.41
Support Level $42.39 $8.23
Resistance Level $43.14 $9.23
Average True Range (ATR) 0.08 0.47
MACD -0.19 0.06
Stochastic Oscillator 71.25 89.70

Price Performance

Historical Comparison
BWMN
PRTA

About BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

Share on Social Networks: